← Open Payments lookup

LORRAINE ROUSE: Open Payments

NPI 1881709707 · LONGWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$724 in 31 payments from 12 companies in 2025. Trend: 2023 $730 · 2024 $1,127 · 2025 $724

Food & beverage: $724
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.5$122
Vanda Pharmaceuticals Inc.4$108
Neurocrine BioSciences, Inc.3$75
E.R. Squibb & Sons, L.L.C.4$75
Janssen Pharmaceuticals, Inc3$65
ABBVIE INC.3$64
Alkermes, Inc.3$62
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$58
Axsome Therapeutics, Inc.1$34
Supernus Pharmaceuticals, Inc.1$24

Products named: ABILIFY ASIMTUFII, INGREZZA, COBENFY, FANAPT, REXULTI, VRAYLAR, CAPLYTA, SPRAVATO.

Industry payments across FL — which companies pay providers there.